Loading...
Loading...

Go to the content (press return)

Fate of priority pharmaceuticals and their main metabolites and transformation products in microalgae-based wastewater treatment systems

Author
Garcia, M.; Arashiro, L.; Santos, L.; Insa , S.; Rodríguez-mozaz, Sara; Barceló Cullerés, Damià; Ferrer, I.; Marianna Garfi'
Type of activity
Journal article
Journal
Journal of hazardous materials
Date of publication
2020-05
Volume
390
First page
121771:1
Last page
121771:14
DOI
10.1016/j.jhazmat.2019.121771
Project funding
Ajut complementari IJCI-2017-34601
Ajut per a contractació RYC-2016-20059
Biogas production from microalgae-bacteria consortia grown in closed photobioreactors for wastewater treatment
Sustainable Product, Energy and Resource Recovery from Wastewater — SuPER-W
Repository
http://hdl.handle.net/2117/180379 Open in new window
https://arxiv.org/abs/2003.06882 Open in new window
URL
https://www.sciencedirect.com/science/article/abs/pii/S030438941931725X Open in new window
Abstract
The present study evaluates the removal capacity of two high rate algae ponds (HRAPs) to eliminate 12 pharmaceuticals (PhACs) and 26 of their corresponding main metabolites and transformation products. The efficiency of these ponds, operating with and without primary treatment, was compared in order to study their capacity under the best performance conditions (highest solar irradiance). Concentrations of all the target compounds were determined in both water and biomass samples. Removal rates r...
Citation
Garcia, M. [et al.]. Fate of priority pharmaceuticals and their main metabolites and transformation products in microalgae-based wastewater treatment systems. "Journal of hazardous materials", Maig 2020, vol. 390, p. 121771:1-121771:14.
Keywords
Bioaccumulation factor, Biomass, Byproducts, Green treatment, High rate algal pond, Low-cost treatment, Photodegradation
Group of research
GEMMA - Group of Environmental Engineering and Microbiology

Participants